GEN3014
GCT3014-01
Phase 2 mab terminated
Quick answer
GEN3014 for Relapsed or Refractory Multiple Myeloma (RRMM) is a Phase 2 program (mab) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated